Stage IA Breast Cancer Recruiting Phase 2 Trials for Exemestane (DB00990)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs